Extended Data Fig. 9: Paranode-enriched and myelin-axon interface Alzheimer’s disease proteomes reveal unique subcellular changes not observed by bulk proteomics or single cell RNA transcriptomics. | Nature Neuroscience

Extended Data Fig. 9: Paranode-enriched and myelin-axon interface Alzheimer’s disease proteomes reveal unique subcellular changes not observed by bulk proteomics or single cell RNA transcriptomics.

From: Myelin–axon interface vulnerability in Alzheimer’s disease revealed by subcellular proteomics and imaging of human and mouse brain

Extended Data Fig. 9

Heatmaps display (a) Paranode Alzheimer’s-associated proteomes (PAPs) and (b) Myelin-axon interface Alzheimer’s proteomes (MAPs). Heatmap denotes log10 (spectral counts). Comparison between PAPs or MAPs and bulk proteomics data (middle panel, Johnson et al.16), or single nuclei RNA sequencing transcriptomics (right panels, Mathys et al.11) were performed. Both bulk proteomics and snRNAseq data were obtained from their original studies. Neuronal cell types (yellow box) and oligodendrocyte/OPC (green box) were highlighted in the snRNAseq data. Abbreviations: FC = fold change; DEG = differentially expressed genes. (A and B) Quantifications of subcellular proteomic data derived from this study were performed two-sided.

Back to article page